Advanced Ophthalmology Products
Ophthalmic diseases
Not DisclosedActive
Key Facts
About Polpharma
Polpharma is a dominant, privately-held generic drug manufacturer in Poland and a key regional player in CEE and CIS markets. With over 4,300 employees, five manufacturing plants, and three R&D centers, it produces approximately 400 million medicine packages annually, holding a ~12.5% share of the Polish pharmacy market and a ~33% share of the hospital market. The company is expanding its international presence, notably with a new office in India, and is investing in innovative drug development in areas like ophthalmology and asthma while maintaining a strong foundation in generics and APIs.
View full company profileTherapeutic Areas
Other Ophthalmic diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Ophtha Pipeline | Origenis | Preclinical |